# Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

> **NCT06274554** · PHASE3 · RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 120 (estimated)

## Conditions studied

- Crohn's Disease
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Placebo
- **BIOLOGICAL:** IL-23 Therapy

## Key facts

- **NCT ID:** NCT06274554
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-04
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06274554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06274554, "Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06274554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*